GlassScriptPhysician profile
Farhan Zaidi
NPI 1508095605
$11,563.37
in general payments reported to CMS, 2019-2025
37 companies · $7,265 in 2025
The $7,265 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $1,610 · 2023: $1,384 · 2024: $1,147 · 2025: $7,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598 · Education: $4,260 · Travel and Lodging: $739 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,597.65 |
| Education | $4,259.97 |
| Travel and Lodging | $738.89 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,738.89 | 2025 | |
| Ethicon INC. | $1,167.66 | 2022-2023 | Monarch Platform |
| Actelion Pharmaceuticals US, INC. | $463.79 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $414.79 | 2022-2025 | Tezspire, Airsupra, Fasenra |
| Grifols USA, LLC | $394.15 | 2023-2025 | Prolastin-C Liquid, Xembify |
| Jazz Pharmaceuticals INC. | $322.32 | 2022-2024 | |
| Glaxosmithkline, LLC. | $314.45 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Galvanize Therapeutics, INC | $295.21 | 2023-2025 | Aliya System |
| Bayer Healthcare Pharmaceuticals INC. | $266.94 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $265.82 | 2024-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $264.75 | 2023-2025 | Glassia |
| Inspire Medical Systems, INC. | $254.88 | 2021-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $223.41 | 2023-2025 | Lumryz |
| United Therapeutics Corporation | $218.48 | 2024-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $207.75 | 2022-2025 | Wakix |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $191.75 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Verona Pharma, INC. | $144.69 | 2025 | Ohtuvayre |
| Genzyme Corporation | $136.66 | 2023-2025 | |
| Axsome Therapeutics, INC. | $127.43 | 2023-2025 | Sunosi |
| Mylan Specialty L.P. | $125.00 | 2022-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.43 | 2022-2025 | Ofev |
| Amgen INC. | $104.06 | 2025 | Tezspire |
| Insmed, INC. | $102.10 | 2022-2025 | Brinsupri, Arikayce |
| Electromed, INC. | $101.68 | 2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Viatris Specialty LLC | $91.21 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $68.10 | 2025 | |
| Merck Sharp & Dohme LLC | $66.32 | 2023-2025 | Zerbaxa, Winrevair |
| Janssen Pharmaceuticals, INC | $51.70 | 2022-2023 | Xarelto |
| Ani Pharmaceuticals, INC. | $46.28 | 2025 | Purified Cortrophin Gel |
| Olympus America INC. | $44.93 | 2023 | Spiration Valve System |
| Resmed Corp | $35.29 | 2025 | |
| Hikma Pharmaceuticals USA | $32.39 | 2023-2024 | Ryaltris |
| Philips North America LLC | $18.89 | 2025 | Vest Therapy Und |
| Erbe USA INC | $17.00 | 2023 | Erbe Vio |
| Inogen, INC. | $16.87 | 2025 | |
| Idorsia Pharmaceuticals US INC | $14.31 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Zaidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.